Do not give any medications to your baby that have not been prescribed by the baby's doctor. This includes vitamins, minerals, or herbal products. Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Every effort has been made to ensure that the information provided by Cerner Multum, Inc. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise.
Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient.
Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
This information does not replace the advice of a doctor. Healthwise, Incorporated, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
Updated visitor guidelines. You are here Home » nitric oxide inhalation gas. Top of the page. What is the most important information I should know about nitric oxide?
If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur.
Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco. The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:.
A nurse or other trained health professional will give your baby this medicine in a hospital. This medicine is inhaled into your baby's lungs through the mouth or nose. This medicine is usually given for up to 14 days or until your baby is ready to be weaned from nitric oxide treatment.
It is very important that your baby's doctor check your baby closely while receiving this medicine. This will allow the doctor to see if the medicine is working properly and to decide if your baby should continue to receive it. Blood tests may be needed to check for unwanted effects. Your baby's doctor also needs to monitor your baby's breathing, oxygen levels, and other vital signs while receiving this medicine.
Stopping this medicine suddenly may increase your baby's risk to have rebound pulmonary hypertension syndrome. Symptoms include: bluish lips or skin, slow heartbeat, lightheadedness, dizziness, or fainting, or decreased cardiac output. This medicine may cause a rare, but serious blood problem called methemoglobinemia. Your baby's doctor will measure how much methemoglobin is in your baby's blood while receiving this medicine. Do not take other medicines unless they have been discussed with your doctor.
This includes prescription or nonprescription over-the-counter [OTC] medicines and herbal or vitamin supplements. Nitric oxide regulation of superoxide-dependent lung injury: Oxidant-protective actions of endogenously produced and exogenously administered nitric oxide.
Haddad, I. Concurrent generation of nitric oxide and superoxide damages surfactant protein A. Mechanisms of peroxynitrite-induced injury to pulmonary surfactants.
Hallman, M. A mechanism of nitric oxide-induced surfactant dysfunction. Pulmonary toxicity associated with nitric oxide in term infants with severe respiratory failure.
Surfactant protein-A, phosphatidylcholine, and surfactant inhibitors in epithelial lining fluid. Surfactant dysfunction after inhalation of nitric oxide. Hamad, A. Heller, R. Nitric oxide inhibits proliferation of human endothelial cells via a mechanism independent of cGMP. Atherosclerosis , 49 — Hill, J. Nitric oxide regulates interleukin 1 bioactivity released from murine macrophages.
Hine, C. Pulmonary changes in animals exposed to nitrogen dioxide, effects of acute exposures. Hoehn, T. Synergistic effects of high-frequency ventilation and inhaled nitric oxide in the treatment of hypoxemic respiratory failure in infancy. Inhaled nitric oxide in premature infants—a meta-analysis. Hovenga, S.
Methaemoglobinemia after inhalation of nitric oxide for treatment of hydrochlorthiazide-induced pulmonary oedema. Ishida, A. Isomura, K. Induction of mutations and chromosome aberrations in lung cells following in vivo exposure of rats to nitrogen oxides.
Johnson, A. Nitrovasodilator repletion increases TNF-alpha-induced pulmonary edema. Kageyama, N. Role of endogenous nitric oxide in airway microvascular leakage induced by inflammatory mediators. Keaney, J. NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties.
Kennedy, M. Activation of poly ADP-ribose synthetases mediates hyperpermeability induced by peroxynitrite in human intestinal epithelial cells. Kermarrec, N. Impact of inhaled nitric oxide on platelet aggregation and fibrinolysis in rats with endotoxic lung injury.
Kinsella, J. Low dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease. Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: A randomized controlled trial. Koppenol, W. Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide.
Kosonen, O. Nitric oxide-releasing oxatriazole derivatives inhibit human lymphocyte proliferation by a cyclic GMP-independent mechanism. Krafte-Jacobs, B. Kwon, N. Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide. Lautier, D. Molecular and biochemical features of poly ADP-ribose metabolism. Liaudet, L. Biology of nitric oxide signaling. Lincoln, T. Intracellular cyclic GMP receptor proteins.
Lindberg, L. Production of nitrogen dioxide during nitric oxide therapy using the Servo Ventilator during volume-controlled ventilation. Acta Anaesthesiol. Maeda, N. A kinetic study on functional impairment of nitric oxide-exposed rat erythrocytes. Health Perspect. Matalon, S. Inhaled nitric oxide injures the pulmonary surfactant system of lambs in vivo. McElroy, M. Nitric oxide attenuates lung endothelial injury caused by sublethal hyperoxia in rats.
Meurs, K. Response of premature infants with severe respiratory failure to inhaled nitric oxide. Preemie NO Collaborative Group. Miura, M. Endogenous nitric oxide modifies antigen-induced microvascular leakage in sensitized guinea pig airways. Allergy Clin. Moellering, D. Nitric oxide-dependent induction of glutathione synthesis through increased expression of gamma-glutamylcysteine synthetase.
Muller, B. Lung surfactant components in bronchoalveolar lavage after inhalation of NO 2 as markers of altered surfactant metabolism. Lung , 61 — Murad, F. Nakajima, W. Methaemoglobinemia after inhalation of nitric oxide in infant with pulmonary hypertension. National Institute for Occupational Safety and Health NIOSH criteria for a recommended standard for occupational exposure to oxides of nitrogen nitrogen dioxide and nitric oxide.
Nelin, L. Nitric oxide increases the survival of rats with a high oxygen exposure. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. New Engl. Neviere, R. Inhaled nitric oxide modulates leukocyte kinetics in the mesenteric venules of endotoxemic rats. Nguyen, T. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Payen, D.
Results of the French prospective multicentre randomized double-blind, placebo-controlled trial on inhaled nitric oxide in ARDS. Intensive Care Med. Peng, H. Quezado, Z. Inhaled nitric oxide: More than a selective pulmonary vasodilator. Cardiopulmonary effects of inhaled nitric oxide in normal dogs and during E. Ripple, G. Kinetics of methemoglobin formation and elimination as a function of inhaled nitric oxide concentration and minute ventilation. Toxicologist 9 , Robbins, C.
Combined effects of nitric oxide and hyperoxia on surfactant function and pulmonary inflammation. Roberts, J. Nitric oxide inhalation decreases pulmonary artery remodeling in the injured lungs of rat pups. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Continuous nitric oxide inhalation reduces pulmonary arterial structural changes, right ventricular hypertrophy, and growth retardation in the hypoxic newborn rat.
Rosenberg, A. Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension. Salgo, M. Peroxynitrite causes DNA damage and oxidation of thiols in rat thymocytes. Sato, E. Inhibition of MIP-1 alpha-induced human neutrophil and monocyte chemotactic activity by reactive oxygen and nitrogen metabolites. Sato, Y. Nitric oxide reduces the sequestration of polymorphonuclear leukocytes in lung by changing deformability and CD18 expression.
Schedin, U. Formation of nitrogen dioxide from nitric oxide and their measurement in clinically relevant circumstances. Schini-Kerth, V.
Vascular biosynthesis of nitric oxide: Effect on hemostasis and fibrinolysis. Sharrock, P. Blood analysis of rabbits exposed to nitrogen monoxide. Chemosphere 13 , — Simon, D. Effect of nitric oxide synthase inhibition on bleeding time in humans. Sokol, G. Nitrogen dioxide formation during inhaled nitric oxide therapy.
Spencer, J. Base modification and strand breakage in isolated calf thymus DNA and in DNA from human skin epidermal keratinocytes exposed to peroxynitrite or 3-morpholinosydnonimine. Stamler, J. Blood-flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient.
Science , — Stavert, D. Nitric oxide and nitrogen dioxide as inducers of acute pulmonary injury when inhaled at relatively high concentrations for brief periods. Subhedar, N. Open randomized controlled trial of inhaled nitric oxide and early dexamethasone in high-risk, pre-term infants. Fetal Neonatal Ed. Szabo, C. Endothelial dysfunction in endotoxic shock: Importance of the activation of poly ADP-ribose synthetases by peroxynitrite. DNA damage induced by peroxynitrite: Subsequent biological effects.
Nitric Oxide 1 , — Peroxynitrite causes energy depletion and increases permeability via activation of poly-ADP ribose synthetases in pulmonary epithelial cells. Cell Biol. Totapally, B. Nitric oxide and nitrogen dioxide concentrations during in vitro high-frequency ventilation. Care 14 , — United States Environmental Protection Agency Wang, S. Nitric oxide increases tumor necrosis factor production in differentiated U cells by decreasing cyclic AMP.
Weinberger, B. Inhaled nitric oxide primes lung macrophages to produce reactive oxygen and nitrogen intermediates. Crit Care Med. Wessel, D. Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertension.
Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics , E7. Winberg, P. Effect of inhaled nitric oxide on raised pulmonary vascular resistance in children with congenital heart disease. Heart J. Wink, D. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors.
Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Xu, L. Activation of the cardiac calcium release channel ryanodine receptor by poly-S-nitrosylation.
Yermilov, V. Formation of 8-nitroguanine in DNA treated with peroxynitrite in vitro and its rapid removal from DNA by depurination. FEBS Lett. Yoshikawa, T. Role of superoxide and nitric oxide in platelet activating factor-induced acute lung injury, hypotension, and mortality in rats. Young, J. Methaemoglobin production in normal adults inhaling low concentrations of nitric oxide.
Yu, S. Circulation 95 , — Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide.
Sign In or Create an Account. Sign In. Advanced Search. Search Menu. Article Navigation. Close mobile search navigation Article Navigation. Volume Article Contents Abstract. Pulmonary Effects of Inhaled Nitric Oxide. Extrapulmonary Effects of Inhaled Nitric Oxide.
0コメント